AB 5 toxins are composed of an enzymatic A subunit that disrupts cellular function associated with a pentameric B subunit required for host cell invasion. EcxAB is an AB 5 toxin isolated from clinical strains of Escherichia coli classified as part of the cholera family due to B subunit homology. Cholera-group toxins have catalytic ADP-ribosyltransferases as their A subunits, so it was surprising that EcxA did not. We confirmed that EcxAB self-associates as a functional toxin and obtained its structure. EcxAB is a prototypical member of a hybrid AB 5 toxin family containing metzincin-type metalloproteases as their active A subunit paired to a cholera-like B subunit. Furthermore, EcxA is distinct from previously characterized proteases and thus founds an AB 5 -associated metzincin family that we term the toxilysins. EcxAB provides the first observation of conserved B subunit usage across different AB 5 toxin families and provides evidence that the intersubunit interface of these toxins is far more permissive than previously supposed.
INTRODUCTION
AB 5 toxins are key virulence factors produced by a range of pathogenic bacteria known to be the causative agents of diseases such as cholera, whooping cough, and dysentery. Each AB 5 protein consists of two components: a pentameric B subunit that targets eukaryotic cells by binding to glycans located at the cell surface and a catalytic A subunit that disrupts host cellular function following internalization. Different families of AB 5 toxins have been categorized according to the level of sequence conservation in the A and B subunits as well as the A subunit's enzymatic activity. Four families are currently known: the Shiga toxins inhibit protein synthesis using a ricin-like catalytic subunit (Fraser et al., 1994) , the pertussis and cholera toxin groups carry unrelated ADP-ribosyltransferases, and SubAB cytotoxin acts as a subtilase-like serine protease (Beddoe et al., 2010) . The B subunits of each family share structural, but not sequence, homology, while the A subunits are only related within a family . Despite structural conservation among their B subunits, each AB 5 protein targets its own cell subpopulations, as minor binding site differences can drastically alter host receptor specificity (Merritt et al., 1997) . Moreover, multiple ligand binding sites within the B subunit can also serve to broaden the target cell specificity (Holmner et al., 2007 (Holmner et al., , 2011 . Additional complexity is also present within the pertussis toxin whose B subunit gene has expanded and diverged, resulting in an atypical heteropentamer (Stein et al., 1994) , so despite the similarities inherent in these toxins, the underlying mechanisms of host cell recognition and disruption can be disease specific.
The pathway of cellular disruption by the cholera AB 5 protein has been well defined and stands as a canonical mechanism of AB 5 action (De Haan and Hirst, 2004) . The toxin's B subunit orchestrates the initial stages of this complex invasive process. Briefly, each B subunit within the pentamer can bind glycolipid headgroups such as those of monosialotetrahexosylganglioside (GM 1 ) at the plasma membrane instigating endocytosis and migration of the holotoxin through the trans-Golgi network to the endoplasmic reticulum (ER) via retrograde trafficking. The A subunit then undergoes proteolytic cleavage into two disulfide-linked sections: a larger enzymatic A1 domain and an A2 domain interfaced with the B5 pentamer. Finally, this disulfide link is actively reduced, permitting A1 domain dissociation and its retrotranslocation to the cytosol where its ADP-ribosyltransferase activity corrupts regulation of fluid secretion.
The cholera-like toxins are the largest subgroup of AB 5 proteins including both the archetype cholera toxin (Ctx) and related heat-labile enterotoxins (LT-I and LT-II). Genes encoding two novel cholera-family B subunits were identified and characterized within clinical isolates of Citrobacter freundii and Escherichia coli derived from diarrheal patients (Karasawa et al., 2002) . These new toxin B subunits were, respectively, named CfxB and EcxB. When the structure of CfxB was solved, it confirmed the placement of these proteins within the cholera group (Jansson et al., 2010) . The B subunits of all previously studied toxins from the cholera group pair with a related series of A subunits, a conserved family of ADP-ribosyltransferases. In contrast, the genes for CfxB and EcxB are located downstream of their respective cfxA and ecxA genes, neither of which encode proteins with homology to any previously studied AB 5 protein (Jansson et al., 2010; Karasawa et al., 2002) . Instead, the A subunits aligned with a group of uncharacterized bacterial proteins with weak homology to zinc-dependent metzincin metalloproteinases (Jansson et al., 2010 ) (20%-25% sequence identity to human matrix metalloproteinase 2 [MMP2]).
In the present study, we have determined the X-ray crystal structure of the entire EcxAB holotoxin to 1.86 Å resolution in both apo-and receptor-bound forms. We confirm that EcxA and EcxB pair together and thus represent a member of the AB 5 toxin superfamily. Furthermore, we demonstrate that EcxA is an endopeptidase that stands as a founding member of a family of metzincin metalloproteases, that of the toxilysins, deserving further characterization. Intriguingly, this EcxA subunit docks with its cholera-like EcxB pentamer through an A2 domain, involving a redox-switching 3 10 helix. EcxAB and CfxAB thus represent founding members of a unique AB 5 family hybrid that comprises B subunits very similar to that of cholera toxin but pair through an entirely different mechanism to an unrelated catalytic A subunit. The EcxAB structure presented here demonstrates a significant level of binding plasticity within cholera-like toxin B subunits. Such binding plasticity may allow a plethora of possible A2 domains to bind, increasing AB 5 toxin evolvability, possibly having implications for the time frames over which pathogenic bacteria and their bacteriophages have been or are able to adapt.
RESULTS

EcxAB, a Novel AB 5 Toxin
The Ecx and Cfx operon structures contain conserved cholera toxin-like B subunit genes (Jansson et al., 2010) downstream of novel A subunit genes (Karasawa et al., 2002) . EcxA and CfxA share 78% sequence identity to each other but are not related to ADP-ribosyltransferases such as CtxA or, indeed, any known AB 5 toxin subunit. Instead, they contain a HExGHxxGxxH motif characteristic of the metzincin family of metalloproteases (Tallant et al., 2010) but only 10-20 conserved residues outside this sequence. We have recently shown that coexpression of EcxA and EcxB results in the formation of a stable heterohexameric protein complex (Ng et al., 2013) , confirming that EcxAB represents an AB 5 toxin. To ascertain whether EcxA truly was a metalloprotease as well as understanding the nature of the EcxAB holotoxin's intersubunit interaction mechanism, we sought to determine its structure. Following optimization, crystals of the purified EcxAB holotoxin could be grown that diffracted to 1.86 Å resolution. An initial model was obtained using CtxB (Merritt et al., 1997) as a molecular replacement model, yielding clear electron density for the remaining A subunit that allowed it to be built (see Experimental  Procedures and Table 1 for details). The final model is largely complete (residues 20-267 and 20-118 for EcxA and B subunits), with only two breaks in electron density corresponding to flexible loops within the A subunit (residues 68-71 and 103-107). The EcxAB crystals contain a single heterohexameric AB 5 complex in the asymmetric unit (63% solvent). The structure has a global organization similar to other AB 5 toxins (Figure 1) , with EcxB adopting a homopentameric ring-shaped assembly. The unique Ecx A subunit is composed of two domains, A1 and A2, linked together via a disulfide bond between residues Cys-208 and Cys-271. Similar, but not structurally homologous, A1-A2 linking disulfides are found in other AB 5 toxins. The C-terminal A2 domain contains an eightamino-acid 3 10 helix that penetrates into the central pore of the B subunit ( Figures 2B and 3) .
The Cholera-like EcxB Pentamer Each monomer of EcxB possesses six antiparallel b strands and two a helices forming an oligonucleotide and oligosaccharide binding fold (OB fold). As in other cholera-family toxins, helix 1 is anchored to b strand 5 via a disulfide bond (Cys-9 to Cys-86) (Jansson et al., 2010; van den Akker et al., 1996) . There are five copies of EcxB within the asymmetric unit that, despite being under the influence of different packing constraints, are essentially identical. We label the five EcxB monomers EcxB 1 to B 5 , and they homooligomerize to form a typical AB 5 -pentameric ring (see Figure 1B) . The structure of each EcxB monomer and its orientation within this pentameric Unit-cell parameters (Å ) 120.7, 120.7, 274.3 120.4, 120.4, 273.4 No assembly are almost identical to those of other cholera family toxins. The closest structural homologs are CfxB (86% sequence identity, root-mean-square deviation [rmsd] of 0.8 Å over 451 C a ) (Jansson et al., 2010) , CtxB (63% sequence identity, rmsd of 0.5 Å over 515 C a ) (Merritt et al., 1997) , and the heat-labile toxin B subunits (66% sequence identity, 0.5 Å over 518 C a with LT-IIb) (van den Akker et al., 1996; see Figure 1 and Figure S1 available online).
Glycan Binding by EcxB
To gain access to host cells, AB 5 toxins bind glycan receptors on the host surface via the B pentamer. The residues making up the cholera toxin's ganglioside GM 1 (Galb3GalNAcb4(NeuAca3) Galb4Glcb1Cer) binding site are largely identical in EcxB, suggesting a conserved mechanism of cell targeting. Accordingly, we sought to understand the receptor specificity of EcxB via glycan array analysis performed at the Consortium of Functional Glycomics (CFG). EcxB showed a high degree of binding specificity for the glycan moiety of ganglioside GM 1 (Galb3GalNAcb4(NeuAca3)Galb4Glcb1Cer) and its fucosylated derivatives but very little binding to other glycans (Table 2) . This is not surprising, as the close homologs CtxB and CfxB also bind GM 1 . CfxB had previously been shown to have an affinity for neolacto-(Galb4GlcNAcb-) and blood group A type 2-(GalNAca3(Fuca2)Galb4GlcNAc) terminated glycans (Jansson et al., 2010) . EcxB showed no affinity for these glycans, suggesting a more cholera-like glycan-binding site. To ascertain whether this was the case, we transferred EcxAB crystals into a solution containing the GM 1 pentasaccharide head group prior to freezing, after which a 1.86 Å data set was collected (see Table  1 for data collection and refinement statistics). The overall structure of EcxAB is largely unchanged by GM 1 binding; those sections of EcxA furthest away from EcxB are not as well defined as in the unliganded structure. Correspondingly, the s4 s5 loop; the s7, s8, and s9 b sheet; and helix 4 have higher B factors following refinement. In contrast the remainder of EcxA and the B pentamer are clearly visible with calculated omit maps showing good density for GM 1 in all five B subunit binding sites (see Figure 4A ). Electron density is clear for each sugar moiety in all sites, allowing five independent copies of the ligand to be built and their interactions to be defined with a high degree of confidence.
The glycan binding site of EcxB is largely equivalent to that of CtxB; all residues forming direct hydrogen bonds with GM 1 are conserved (see Figures 4A and 4B ). The similarities of the glycan binding sites in EcxAB and CtxAB suggest that they target similar cellular subtypes. Comparisons made between cholera and heat-labile toxins have shown that minor differences within the glycan binding sites nevertheless leads to substantial effects on specificity (Holmner et al., 2011) ; the affinity of EcxAB for GM 1 was thus determined by surface plasmon resonance (SPR) ( Figure 4C ). A kinetic analysis of EcxAB binding as measured by SPR could not be modeled with an appropriate fit due to the multivalent nature of the EcxB pentamer. However, an apparent K D was determined by pseudoequilibrium analysis, a method used for other AB 5 toxins in previous publications. The apparent dissociation constant, K D , of EcxAB for binding to GM 1 is 32 ± 2 nM, and as expected, given the level of sequence identity within their binding sites, is similar to that published for CfxB See also Figure S1 and 3D Molecular Model S1. (Jansson et al., 2010) and CtxB (MacKenzie et al., 1997; Masserini et al., 1992) . While the nature of their GM 1 binding sites appears conserved, CfxB binds to blood group A type 2 antigens (Jansson et al., 2010) while glycan arrays indicate that EcxB does not. Such antigens bind the B subunit of the heat-labile toxin using an alternate binding site on the circumferential edge of the pentamer (Holmner et al., 2007) . Most residues making up this novel antigen site in LT-IB are conserved across both CfxB and EcxB, including a tyrosine and threonine thought to be important for recognition; further work is needed to confirm differences in blood antigen specificity across the cholera-group B subunits that will aid an analysis of the determinants for this secondary ligand site.
The Unique A Subunit-EcxA The EcxA subunit is a globular protein consisting of nine a helices, one 3 10 helix, and three antiparallel b sheets containing 12 strands in total (see Figures 1, 2A , and 2C). While EcxA and CtxA share no sequence similarity, there remained the possibility that they could share structural homology. This was not the case; however, a structure-based search of the Protein Data Bank (PDB) using ''Fold'' (Krissinel and Henrick, 2004) identified the closest known homolog being that of an inactive form of human pro matrix metalloprotein 2 (Protein Data Bank [PDB] ID, 1EAK; rmsd of 2.1 Å over 116 of 282 C a , 19 of the 116 residues are conserved). The degree of structural conservation is low, and EcxA could equally well be described as having homology to the catalytic cores of a number of metzincin proteases. Indeed, the majority of conservation between EcxA and MMP2 exists within their respective zinc-binding motifs (residues HExGHxxGxxH; Figure 2 and Figure S3 ). Despite low sequence similarity between EcxA and MMP-2, the catalytic sections of the fold are largely conserved, implying that EcxA is indeed a metzincin protease (Figure 2 ). This is not without precedent; an unrelated serine protease makes up the enzymatic A subunit of the subtilase cytoxin AB 5 family (Paton et al., 2004) .
The structural core of EcxA resembles that of other metzincintype metalloproteases. This fold is described as consisting of an upper subdomain prior to the consensus motif and a lower C-terminal subdomain following it (Tallant et al., 2010) ; this rough division results in the subdomains lying on either side of the peptide-binding cleft overlaying the active-site helix (h6 in EcxA). In EcxA, this classical metzincin fold division is confused, as N-terminal residues form an integral part of the C-terminal subdomain structure. The lower subdomain of EcxA could be described as the base sitting atop the B subunits; this consists of one of the b sheets (s1, s10, s11, s12, s2), a backing helix (h8), an N-terminal helix (h1), and several long loops (elements shown as partially transparent in Figure 2A ). The upper subdomain of EcxA, like other metzincins, contains most of the catalytic machinery: the active-site helix provides two of three zinc-coordinating histidines (H   179   EIGH 183 ) and the proposed catalytic base Glu-180
( Figure 2 ). The third metal-coordinating histidine, His-189, arises from the loop immediately C terminal to helix 6. Electron density provides clear evidence for a metal ion coordinated by these three histidines in EcxA (greater than 10 s peaks in omit and anomalous difference Fourier maps). This ion is modeled as zinc due to a peak in X-ray fluorescence scans and homology with the catalytic sites of other metzincins. The ion has a distorted square pyramidal coordination to the three-histidine's epsilon nitrogens and two water molecules. loop (Tallant et al., 2010) . In MMPs, this Met turn is directly C terminal to helix 6 (see Figure 2B) . EcxA, instead, has a large loop inserted at this point that delves toward the B pentamer, with b strands s10 and s11 extending the lower subdomain's b sheet before returning 29 residues later to form a Met turn. The returning s11 loop is important as it contains Cys-208, which participates in the A subunit's only disulfide bond. AB 5 toxins frequently contain a redoxsensing disulfide whose reduction inside the host cell acts as a switch to promote subunit dissociation and A subunit activation. As discussed later, in Ecx, this disulfide is in an unusual position directly above the B subunits' pentameric pore. When compared with other metzincins, EcxA thus contains structural elements inserted within its catalytic machinery that extend to interface with the toxin B subunits. The intact nonreduced EcxAB holotoxin showed no proteolytic activity in a nonspecific small scale test (see Figure S4D) . Active metzincins have a hydrophobic cavity adjacent to the catalytic zinc ion. A large aromatic residue within the substrate inserts into the cavity, p-stacking with a metal-coordinating histidine while forming backbone and side chain interactions with a conserved tyrosine within the substrate loop. In the EcxAB structure, the substrate loop of EcxA does not adopt an active conformation; what should be a hydrophobic pocket next to the zinc ion is instead large and polar. The missing pocket is due to the conformation of the EcxA substrate-binding loop; although a tyrosine is present, instead of forming one wall of the hydrophobic pocket, it is oriented away from the active site and toward the B pentamer (see Tyr-224 and pink substrate loop in Figure 2A ). The B-subunit-bound form of EcxA may thus represent that of a proenzyme, the correct folding of the A subunit's catalytic machinery potentially requiring its dissociation from the pentameric ring following cellular delivery.
EcxA, Prototype for a Toxilysin Metzincin Family
Proteins within each metzincin family share similar ancillary additions to their core metalloprotease fold arising out of conserved family-specific sequences (Gomis-Rü th, 2009). One such characteristic region occurs within the loop spanning between the zinc-binding HExGHxxGxxH motif and the subsequent conserved methionine turn, residues important for enzymatic activity and substrate specificity (Gomis-Rü th, 2003). The sequence of this region shows considerable homology among family members to the point of ''family-specific'' residue positions being defined C terminal to the third histidine and two residues N terminal to the methionine turn. The remainder of the zinc-binding/Met-turn sequence is also used to help identify members of a particular metzincin family, even if they otherwise have low homology outside this region. This loop within EcxA (residues 179-218; Figure 2C ) is elongated through insertion of the s10, s11 b strands and did not immediately resemble previously defined metzincin family sequences (Gomis-Rü th, 2009). We thus compared the structure of EcxA to metzincins from each major family. This was done with particular focus on metzincins with large loops within their zinc-binding/Met-turn sequence including the astacins, serralysins, pappalysins, cholerilysins, and leishmanolysins but also the snapalysins because of their single conserved cysteine within this loop (Gomis-Rü th, 2009). The structure of the EcxA zinc-binding/Met-turn loop diverges from that observed in other metzincins; it is part of the B-pentamer-interacting loop that contains half of the AB 5 redox switch and extends the lower subdomain's b sheet, a pentamer-interacting b sheet that is one of several features marking the EcxA metzincin fold as significantly different from previously observed structures. Other aspects include the insertion of two short helices (h4 and h5) N terminal to the active-site helix that also line one end of the EcxA substrate cleft and a two-stranded s4 s5 b sheet wrapping around the back of the molecule (see Figure 2A) . A lack of sequence conservation and the sheer disparity between the EcxA structure and previously solved metzincins, as well as its exclusive association as part of a heterohexameric AB 5 toxin, would attest that this protein stands as a prototype for a family of metzincin proteases, a family that we propose to call the toxilysins. This metzincin family includes EcxA and CfxA-type proteins (e.g., BAC16523, WP_016231354, WP_001575760, and BAC16521) and, potentially, a number of other related proteins that are yet to be fully characterized. We are working to define the characteristic sequence determinants and substrate specificity for the family but would expect the zinc-binding/Met-turn sequence to resemble
The potential length of this loop, the necessity of the conserved asparagine, and the position of the redoxswitch cysteine are all aspects, for some variability in other family members could be expected. It will next be important to characterize the substrates, activation mechanism, and sequence determinants of the toxilysin family of proteases.
The Ecx Oligomerization Interface
The B subunits of the AB 5 toxins oligomerize to form stable pentameric rings that bind to their respective A subunits. The OB folds of the toxins' B subunit are well conserved, their oligomerization yielding a central pore $15 Å in diameter symmetrically lined with five copies of the residues from one face of the B subunits' longest h2 helix. One of the stabilizing features of the mature holotoxins is the insertion of the A subunit's C-terminal A2 helix directly into the central pore of the pentamer. The residues lining the pore vary in different proteins, but the two ends can generally be ascribed distinct characteristics (see Figure S2) ; the end directly interfacing with the A subunit is frequently hydrophobic, presenting a cylindrical interaction surface for the respective toxin's A2 helix (Tinker et al., 2003) . In contrast, the membrane-proximal side of the channel is more often charged or polar in character.
The A2 helices of different AB 5 toxin families are unrelated. They vary in overall length and angle of approach to the pore (Figure 3 ), but the segment contained within the pentameric ring is globally similar. An archetypical toxin C terminus enclosed by its B subunit ring would be described as consisting of a centrally aligned A2 a helix exactly matched in size to the hydrophobic half of the pore that then transitions into a looser strand-like structure, with a smaller diameter, that may be poorly defined at the pore's membrane-proximal end (see Figure 5) . The A2 segment of Ecx is unorthodox for two reasons: first, the A subunits activating intramolecular disulfide resides immediately above the pore, with Cys-271 being the N-capping residue of a short A2 helix (see Figure 3B) ; second, instead of forming an a helix at the center of the pore, it is the first toxin to contain an off-center 3 10 helix that does not completely fill the space provided (see Figure 3A ).
An average a helix is 12 Å in diameter including side chains; this provides an almost perfect match to the diameter of the B subunit's pentameric pore. The off-center orientation and Data are presented for a selection of 6 of the 511 glycans present on the array; a histogram plot of the entire array is presented in Figure S4E . smaller diameter of the Ecx A2 helix result in its making drastically different interactions with the different EcxB subunits. The A2 helix itself is eight residues long and alternates between large hydrophobic residues on one side and small glycine or alanine residues on the other. Inside the pore, the large hydrophobic leucine and phenylalanine residues pack against the three Phe-99 side chains of subunits EcxB 1 , B 2 , and B 5 (see Figure 3B ). The EcxA:EcxB complex is stabilized further by polar contacts to the C termini of helix 2 in EcxB 5 , B 3 , and B 4 (see Figures 3B and  3C ). The charged hydrogen bonds made by Arg-207 and Arg-209 with the backbone of EcxB 4 are particularly interesting, as Cys-208 is the other half of the activating disulfide. Thus, the two cystines of the EcxA intramolecular disulfide are located next to major elements of the EcxA:EcxB interface: the A2 helix for Cys-271 and the s11 arginine loop for Cys-208. AB 5 toxins usually contain an A1-A2 linking intramolecular disulfide that is reduced following internalization, resulting in dissociation of the A subunit and its activation. The integral nature of the disulfide within the EcxAB intersubunit interface makes it easy to see how its reduction could promote such dissociation. Moreover, as the s11 arginine loop lies beneath the catalytic zinc ion of EcxA within the zinc-motif/Met turn loop, this could also provide a means by which dissociation could affect activation of the peptidase. EcxB and CtxB show 63% sequence identity and almost complete structural homology, yet their A subunits are distinct. How is it possible for a common B subunit usage to exist in the cholera and Ecx families of toxins? Prior to the structure of Ecx, the sequence homology of AB 5 toxins indicated that they existed as closely matched pairs, coevolving a highly stable interaction mechanism. There are only three residue differences between EcxB and CtxB within their respective A subunit binding sites. Despite this, the two pentamers carry completely unrelated cargo proteins attached through divergent A2 interaction mechanisms. The three substitutions in EcxB/CfxB correspond to Gly-101, Phe-99, and Ala-96 (respectively, Glu-79, Leu-77, and Ile-74 in Ctx; see Figure S1 ). These residues are all part of the hydrophobic mouth of the pentameric pore, and mutational studies have proven their equivalents to be important for A subunit binding in CtxB (Tinker et al., 2003) . Apart from its A2 helix, the intersubunit interactions of EcxA are mostly made with backbone groups of EcxB (see Figure 3B ). Providing that pentaradiate symmetry is maintained, many residue changes could thus potentially be tolerated within the B subunit using an A2 3 10 helix interface. The presence of Ala-96 in EcxB instead of the CtxB isoleucine would seem necessary to allow for the off-center binding mode of the 3 10 helix. However, the converse does not appear to be true, as LT-IIb binds its A2 helix with an Ala in this position. Chimeric AB 5 toxins prove that residue changes in the A2 region can alter holotoxin stability and may be all that lies between the potency differences of cholera and heat-labile enterotoxins (Rodighiero et al., 1999) . The structure of EcxAB suggests that such intersubunit interactions with the B subunits of AB 5 proteins are more permissive and less fine-tuned than previously thought.
Cytotoxic Activity of EcxAB
Cytotoxicity of the EcxAB protein was examined in several cell lines, of which the most sensitive were Chinese hamster ovary (CHO) cells. Treatment of subconfluent CHO monolayers with 5 mg/ml EcxAB holotoxin induced a pronounced cell rounding effect after 24 hr incubation. This effect was dependent on the presence of the enzymatic A subunit, as no cytopathic effect was seen when cells were treated with a similar concentration of EcxB (Figure 6 ). Cytopathic effects were not seen in Vero (African green monkey kidney) cells treated with EcxAB (data not shown). Differential susceptibilities of cell lines to distinct AB 5 toxins is commonplace. For example, Vero cells are highly susceptible to both SubAB and Stx (50% cytotoxic doses in the picogram range for both toxins), whereas CHO cells are susceptible to SubAB but refractory to Stx (Paton et al., 2004 ). This Four AB 5 toxin classes have been defined via shared sequence relationships in both their A and B subunits. The structures of known AB 5 holotoxins divided into their respective classes are displayed using the same colors for subunits with sequence homology. The pentameric B subunit is shown using a partially transparent surface representation. The A subunits with cartoon representations in which the A2 domain is highlighted in pink are shown. The activating disulfide is shown using a yellow dot.
is attributable, at least in part, to differences in expression of the distinct cognate glycan receptors (a2-3-linked N-glycolylneuraminic acid glycans and the glycolipid globotriaosyl ceramide for SubAB and Stx, respectively) (Byres et al., 2008; Paton and Paton, 1998) . Clearly, levels of expression of GM 1 on the surface of target cells would be expected to influence susceptibility to EcxAB, possibly accounting for low potency. However, whether a cytotoxic phenotype is visible at the microscopic level in a given cultured cell line is also dependent on the physiological consequences of A-subunit-mediated covalent modification of its target molecule. Whereas Stx and SubAB cause lethal damage in Vero cells, other AB 5 toxins may have more subtle effects. Ctx, for example, is bound and internalized by Vero cells, confirming display of the cognate receptor GM 1 , but it exerts no obvious cytopathic phenotype in this cell line. The culture supernatants of bacterial isolates expressing Ecx/Cfx also show low cytotoxicity in suckling mouse and CHO cell assays (Karasawa et al., 2002) . Thus, the Ecx family may be relatively low potency toxins. Further work is ongoing to identify the substrate(s) of EcxAB and to characterize its mechanism of action and its transport following cellular uptake.
Conclusions
It is somewhat a dichotomy that the different AB 5 toxin classes have structurally related B subunits while their respective A subunit cargos radically diverge. This has led to the hypothesis that the B subunits evolved into an efficient cellular delivery and internalization system that became independently partnered with a variety of toxic A subunits (Beddoe et al., 2010) . The A subunits of the different toxin classes may have convergently evolved unrelated connection systems utilizing C-terminal A2 helices and redox-switch release mechanisms, because this is a highly effective way for a protein to be transported into a host, sense their surroundings, and then dissociate. The EcxAB holotoxin structure presented here provides a prototype for a family of AB 5 toxins, one that is a partial hybrid with the cholera family and fits this evolutionary hypothesis well. The Ecx/Cfx family of toxins is found in at least two bacterial species (Karasawa et al., 2002) and could be present in many more. EcxB shares 63% sequence identity to CtxB, and, structurally, the two proteins overlay almost perfectly, indicating close evolutionary links. This is in juxtaposition to EcxA, which is not an ADP-ribosyltransferase like previous cholera family toxins but rather is a novel metalloprotease. Moreover, EcxA has a unique A2-interacting domain comprising a redox-switch-linked 3 10 helix immediately above the pentamer pore. The novel nature of the metzincintype metallopeptidase domain of EcxA and its B subunit-binding mechanism can only mean that Ecx and Ctx toxins have independently evolved their pairing to an ancestral cholera family B subunit with minimal divergence since this time. Ecx toxin presents a model for AB 5 toxins that will force us to adapt our current family definitions if drastically different toxin A subunits can bind to almost identical B subunits. This remarkable ability of AB 5 proteins to recruit new toxic payloads is demonstrated in an even more ad hoc manner in the case of the Typhoid toxin (Song et al., 2013) ; this toxin consists of a Pertussis-like AB 5 heterohexamer but one in which a second catalytic subunit is added on to the first pentamer-inserting A subunit through the evolution of a novel intermolecular disulfide crosslink.
The isolated B subunit structure of the C. freundii CfxAB is homologous to that of EcxB (Jansson et al., 2010) . However, while Jansson et al. characterized the specificity of CfxB, they were unclear whether they had correctly identified the CfxA subunit, as its A2 domain shared no homology with Ctx or LT-I. The sequence identity between CfxA and EcxA allows us to conclude that not only is it a toxilysin metallopeptidase, but also that it would bind to its B subunit utilizing an A2 3 10 helix. Experiments are being performed to determine any posttranscriptional steps required for activation of this family of AB 5 toxin metalloproteases and which host proteins are their substrates. The Ecx toxin family was identified from bacterial isolates of patients with clinical diarrhea due to its B subunit's relationship to CtxB (Karasawa et al., 2002) . Despite this, the enzymatic A subunit normally thought of as responsible for disease causation is not conserved. This raises some unusual questions: Does EcxA induce secretory diarrhea by increasing Cl À efflux through an independent cellular pathway? If so, why would Ecx and Ctx, two distinct toxins identified by linked disease pathology, share a common B subunit cargo carrier? Is this a case of multiple bacterial strains occupying common environmental niches leading to horizontal gene transfer, and, if so, how rapid is this process? Rates of cholera infection are greatly reduced following immune stimulation by the inactivated whole cell/recombinant B subunit vaccine. This vaccine is targeted toward V. cholerae infection yet also provides a measure of protection against enterotoxigenic E. coli due to homology between the two toxins' B subunits (Torrell et al., 2009 ). The vaccine's makeup may be even more fortuitous if cholera-like B subunits are found in clinically relevant pathogens utilizing AB 5 toxins with distinct catalytic domains. Briefly, EcxA and EcxB were cloned for periplasmic coexpression within E. coli B21(DE3) then purified by a combination of immobilized metal affinity and size exclusion chromatography.
Cloning, Expression, and Purification of a Refolded Form of EcxAB Two gene constructs for EcxA and EcxB, containing their respective native signal sequence, were synthesized by GenScript. The EcxA construct contained NcoI and NotI restriction sites at the N and C termini, respectively, with these sites used to subclone from the pUC57 cloning vector into the MCS1 of the pETDuet-1 expression vector (Novagen). The EcxB construct contained NdeI and XhoI restriction sites at the N and C termini, respectively, with these sites used to subclone from the pUC57 cloning vector into the MCS2 of the pETDuet-1 expression vector.
The EcxA-and EcxB-encoding plamids were transformed into E. coli BL21(DE3) cells following sequence verification, and EcxA and EcxB were expressed in an insoluble form as inclusion bodies. The cells were grown in Luria broth containing 100 mg/ml ampicillin to an optical density 600 of 0.6. BL21(DE3) cells were induced by the addition of 1.5 mM isopropyl-b-D-1-thiogalactopyranoside for 4 hr. Cell culture pellet was collected following centrifugation at 5000 3 g for 20 min at 4 C, resuspended in Tris-buffered saline, and stored at À20 C. The cell pellet was thawed, lysed using a cell disruptor (Avestin), and centrifuged at 30,000 3 g for 30 min at 4 C. Inclusion bodies were washed twice with 50 mM Tris-HCl, pH 8, 100 mM NaCl, 1 mM b-mercaptoethanol, 0.2 mM phenylmethanesulfonylfluoride (PMSF), 0.5% Triton X-100, and then washed once with 50 mM Tris-HCl, pH 8, 1 mM b-mercaptoethanol, 0.2 mM PMSF. Following washing, the inclusion bodies were dissolved in 20 ml resolubilization buffer containing 6 M guanidine hydrochloride, 100 mM Tris-HCl, pH 8, 5 mM b-mercaptoethanol. The solubilized pellet was slowly diluted into 2 l refold buffer containing 50 mM Tris-HCl, pH 8, 500 mM NaCl, 5 mM imidazole and stirred overnight at room temperature. Purification of the refolded form of EcxAB is as described for the soluble form.
Cytotoxicity Assay
Cytotoxocity assays were performed using CHO and Vero cells, as described elsewhere (Paton et al., 2004) .
Crystallization and Data Analysis
Apo Form of EcxAB Crystals were grown using the hanging-drop, vapor-diffusion method, with a 1:1 (v/v) ratio of EcxAB to mother liquor (well volume, 1 ml). Appearance of crystals from the soluble form of EcxAB occurred within 3 days in 4% tacsimate, pH 4.5, 10% polyethylene glycol 3350. Crystals were flash-frozen in liquid nitrogen before data collection with 20% glycerol as the cryoprotectant. EcxAB with GM1 Pentasaccharide Bound Crystals were grown using the hanging-drop, vapor-diffusion method, with a 1:1 (v/v) ratio of EcxAB to mother liquor (well volume, 1 ml). Appearance of crystals from the refolded form of EcxAB occurred within 3 days in 0.8 M NaH 2 PO 4 , 0.8 M KH 2 PO 4 , 0.1 M HEPES Na, pH 7.5. GM1 pentasaccharide (Enzo Life Sciences) was added so that the final concentration was approximately 10 mM in drops containing preformed crystals. GM1 was allowed to soak into these crystals for 3 days before flash-freezing in liquid nitrogen and subsequent data collection, using 2 M CH 3 CO 2 K as the cryoprotectant.
Structure Determination
All diffraction data were collected at 100K on beamline MX2 of the Australian synchrotron. Diffraction data from crystals of the apo-and GM1-soaked EcxAB were obtained at 1.86 Å and 1.80 Å , respectively. The crystals belong to the spacegroup P6 5 22 and contain one molecule in the asymmetric unit. The structure of apo EcxAB was obtained using a single chain of CtxB (Merritt et al., 1997) (PDB ID 2CHB) as a molecular replacement model in the program PHASER (McCoy, 2007; McCoy et al., 2007) . As no close homolog of the A subunit was initially identified, ARP/wARP (Langer et al., 2008; Murshudov et al., 2011) was used to build a starting model for the A subunit. A largely complete holotoxin structure resulted, followed by rounds of manual building and refinement. Model building and structural validation were completed using the CCP4 suite , PHENIX (Adams et al., 2010) , and Coot (Emsley et al., 2010) . Solvent molecules were retained only if they had acceptable hydrogen bonding geometry contacts of 2.5 Å -3.5 Å with protein atoms or with existing solvent and were in good 2F o À F c electron density. The final holotoxin model consists of residues 22-126 from five EcxB molecules, residues 21-67, 72-102, and 108-282 from EcxA and a Zinc ion. The GM1-soaked structure was obtained using the apo EcxAB as a molecular replacement model; electron density was clear for all sugar moieties of all five GM1 molecules. A summary of data collection and refinement statistics is provided in Table 1 .
Glycan Array Analysis
Purified EcxAB protein at 0.2 mg/ml was applied to a glycan microarray slide at the CFG Protein-Glycan Interaction Core at Emory University. Binding was detected using fluorescence-conjugated anti-hexahistidine antibody. The data are reported as average relative fluorescence units of four of six replicates (after removal of the highest and lowest values) for each glycan represented on the array.
SPR Analysis
All SPR experiments were conducted at 25 C on a BIAcore 3000 instrument using HEPES-buffered saline (10 mM HEPES-HCl, pH 7.4, 500 mM NaCl, and 0.005% P20 [v/v] ). Biotinylated synthetic carbohydrates utilized in the SPR studies were obtained either from the CFG Glycan Array Synthesis Core or GlycoTech. The biotinylated glycans-CH 2 CH 2 NH 2 -biotin (Sp0), Galb(1-4)-Glca-Sp0-biotin, GM1-Sp0-biotin, and aNeu5Ac-Sp0-biotinwere immobilized on an SA-Chip (GE Healthcare) with a surface density of approximately 200 response units. Various concentrations of EcxAB (1.17 to 350 nM) were injected over the captured glycans at 10 ml/min. The surface was regenerated with two injections of 4 M MgCl 2 at 100 ml/min between injections of EcxAB. The final response was calculated by subtracting the response of the blank flow cell alone (Sp0) from the EcxAB-glycan complex. The equilibrium data were analyzed using GraphPad Prism.
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